Voloridge Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-271,852
| Closed | -$2.39M | – | 1392 |
|
|
2023
Q4 | $2.39M | Sell |
271,852
-272,595
| -50% | -$2.4M | 0.01% | 791 |
|
|
2023
Q3 | $6.24M | Buy |
544,447
+113,351
| +26% | +$1.3M | 0.03% | 590 |
|
|
2023
Q2 | $10.9M | Buy |
431,096
+266,070
| +161% | +$6.73M | 0.05% | 438 |
|
|
2023
Q1 | $5.32M | Sell |
165,026
-94,427
| -36% | -$3.04M | 0.03% | 649 |
|
|
2022
Q4 | $4.79M | Sell |
259,453
-289,154
| -53% | -$5.34M | 0.03% | 655 |
|
|
2022
Q3 | $14.8M | Buy |
548,607
+245,531
| +81% | +$6.63M | 0.08% | 334 |
|
|
2022
Q2 | $4.19M | Buy |
303,076
+96,271
| +47% | +$1.33M | 0.02% | 742 |
|
|
2022
Q1 | $4.03M | Sell |
206,805
-12,238
| -6% | -$239K | 0.02% | 711 |
|
|
2021
Q4 | $3.58M | Buy |
+219,043
| New | +$3.58M | 0.02% | 843 |
|
|
2020
Q2 | – | Sell |
-13,757
| Closed | -$204K | – | 1557 |
|
|
2020
Q1 | $204K | Buy |
+13,757
| New | +$204K | 0.01% | 948 |
|
|
2019
Q4 | – | Sell |
-19,522
| Closed | -$254K | – | 1397 |
|
|
2019
Q3 | $254K | Buy |
+19,522
| New | +$254K | ﹤0.01% | 963 |
|
|
2019
Q2 | – | Sell |
-20,151
| Closed | -$318K | – | 1139 |
|
|
2019
Q1 | $318K | Buy |
+20,151
| New | +$318K | 0.01% | 789 |
|